Metformin-based oral antihyperglycemic combination therapy and risk of dementia in patients with newly diagnosed type 2 diabetes: A population-based study. [PDF]
Alzheimers DementHsieh TC, Chen HH, Chang WC, Ho CP.
europepmc +1 more source
Glaucoma Risk with Metformin and Sulfonylurea Therapies in Type 2 Diabetes: A Retrospective Cohort Study. [PDF]
Clin OphthalmolLim J, Zhou J, Wu H, Liu Z, Lee DA.
europepmc +1 more source
Medication time of metformin and sulfonylureas and incidence of cardiovascular diseases and mortality in type 2 diabetes: a pooled cohort analysis. [PDF]
Sci RepBahardoust M +4 more
europepmc +1 more source
Comparative cardiovascular risk of sulfonylureas with low- and high-affinities for cardiac mitochondrial adenosine triphosphate-sensitive potassium channels versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: A cohort study. [PDF]
Diabetes Obes MetabChen MH +8 more
europepmc +1 more source
Editorial for the Special Issue "Cytochrome P450 (CYP) in Health and Disease". [PDF]
BiomedicinesGrishanova A.
europepmc +1 more source
SGLT2 inhibitors for primary prevention of macrovascular and major microvascular complications in type 2 diabetes: an island-wide cohort study. [PDF]
J R Soc MedCheng WY +7 more
europepmc +1 more source
Sulfonylurea drugs for people with severe hemispheric ischemic stroke. [PDF]
Cochrane Database Syst RevFan L +5 more
europepmc +1 more source
Glucagon-like Peptide-1 Receptor Agonists in Asthma Exacerbations: An Application of High-Dimensional Iterative Causal Forest to Identify Subgroups. [PDF]
Pharmacoepidemiol Drug SafWang T +9 more
europepmc +1 more source
New Potent Sulfonamide-Based Inhibitors of <i>S</i>. <i>aureus</i> Biotin Protein Ligase. [PDF]
ACS Med Chem LettStachura DL, Kalyvas JT, Abell AD.
europepmc +1 more source
Clinical perspectives of new insights and tools to minimize the hypoglycaemia burden connected with type 2 diabetes pharmacotherapy. [PDF]
Cardiovasc DiabetolStandl E +4 more
europepmc +1 more source